IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 123 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,715,969 | +52.0% | 280,846 | +59.0% | 0.05% | +46.9% |
| Q4 2022 | $1,128,640 | +332.4% | 176,626 | +1193.3% | 0.03% | +100.0% |
| Q4 2021 | $261,000 | -55.2% | 13,657 | -42.3% | 0.02% | -65.2% |
| Q3 2021 | $583,000 | -47.0% | 23,652 | -32.0% | 0.05% | -54.5% |
| Q1 2021 | $1,100,000 | +99.6% | 34,757 | +107.7% | 0.10% | +188.6% |
| Q3 2020 | $551,000 | -58.1% | 16,733 | -65.0% | 0.04% | -61.5% |
| Q2 2020 | $1,314,000 | +150.8% | 47,870 | -13.1% | 0.09% | +145.9% |
| Q1 2019 | $524,000 | +88.5% | 55,079 | +122.7% | 0.04% | +76.2% |
| Q3 2018 | $278,000 | +115.5% | 24,732 | +144.5% | 0.02% | +133.3% |
| Q2 2018 | $129,000 | +4.0% | 10,114 | -34.6% | 0.01% | -35.7% |
| Q4 2017 | $124,000 | -59.6% | 15,464 | -60.9% | 0.01% | -81.8% |
| Q3 2017 | $307,000 | – | 39,590 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |